Detailed information for compound 49648

Basic information

Technical information
  • TDR Targets ID: 49648
  • Name: potassium 4-(2,6-dioxo-1-propyl-3,7-dihydropu rin-8-yl)benzenesulfonate
  • MW: 388.44 | Formula: C14H13KN4O5S
  • H donors: 2 H acceptors: 6 LogP: 0.66 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCn1c(=O)[nH]c2c(c1=O)nc([nH]2)c1ccc(cc1)S(=O)(=O)[O-].[K+]
  • InChi: 1S/C14H14N4O5S.K/c1-2-7-18-13(19)10-12(17-14(18)20)16-11(15-10)8-3-5-9(6-4-8)24(21,22)23;/h3-6H,2,7H2,1H3,(H,15,16)(H,17,20)(H,21,22,23);/q;+1/p-1
  • InChiKey: CJOWSBOERSTJAR-UHFFFAOYSA-M  

Network

Hover on a compound node to display the structore

Synonyms

  • potassium 4-(2,6-diketo-1-propyl-3,7-dihydropurin-8-yl)besylate
  • 1-Propyl-8-(4-sulfophenyl)xanthine potassium salt hydrate
  • P0373_SIGMA
  • PSB 1115 potassium salt hydrate

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adenosine A2b receptor Starlite/ChEMBL References
Rattus norvegicus Adenosine A1 receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus multilocularis neuropeptide receptor Adenosine A1 receptor   326 aa 299 aa 22.4 %
Loa Loa (eye worm) hypothetical protein Adenosine A1 receptor   326 aa 300 aa 24.3 %
Schistosoma japonicum Alpha-1A adrenergic receptor, putative Adenosine A1 receptor   326 aa 295 aa 28.1 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 323 aa 20.7 %
Schistosoma mansoni peptide (allatostatin)-like receptor Adenosine A1 receptor   326 aa 327 aa 24.8 %
Schistosoma mansoni neuropeptide receptor Adenosine A1 receptor   326 aa 274 aa 22.6 %
Schistosoma mansoni neuropeptide receptor Adenosine A1 receptor   326 aa 311 aa 21.2 %
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Adenosine A1 receptor   326 aa 317 aa 24.6 %
Schistosoma mansoni dro/myosuppressin receptor Adenosine A1 receptor   326 aa 326 aa 22.1 %
Brugia malayi hypothetical protein Adenosine A1 receptor   326 aa 305 aa 21.0 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Adenosine A1 receptor   326 aa 315 aa 21.6 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 306 aa 21.2 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Adenosine A1 receptor   326 aa 321 aa 22.7 %
Onchocerca volvulus Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog Adenosine A1 receptor   326 aa 286 aa 22.7 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 304 aa 21.1 %
Loa Loa (eye worm) neuropeptide F receptor Adenosine A1 receptor   326 aa 316 aa 19.9 %
Schistosoma japonicum 5-hydroxytryptamine receptor 4, putative Adenosine A1 receptor   326 aa 286 aa 26.9 %
Echinococcus granulosus thyrotropin releasing hormone receptor Adenosine A1 receptor   326 aa 321 aa 23.1 %
Echinococcus granulosus allatostatin A receptor Adenosine A1 receptor   326 aa 303 aa 24.1 %
Echinococcus multilocularis allatostatin A receptor Adenosine A1 receptor   326 aa 303 aa 24.1 %
Echinococcus granulosus neuropeptide receptor Adenosine A1 receptor   326 aa 299 aa 22.4 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.144 0.144
Trichomonas vaginalis PIKK family atypical protein kinase 0.0033 0.2521 0.2521
Trypanosoma cruzi target of rapamycin kinase 3 0.0035 0.2799 0.6934
Trichomonas vaginalis PIKK family atypical protein kinase 0.0044 0.3879 0.3879
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.2134 0.2134
Trichomonas vaginalis PIKK family atypical protein kinase 0.0033 0.2521 0.2521
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0044 0.3879 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0044 0.3879 0.3653
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0044 0.3879 1
Echinococcus granulosus 3-phosphoinositide-dependent protein kinase 1 0.0095 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0033 0.2521 0.2521
Trichomonas vaginalis AGC family protein kinase 0.0095 1 1
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.0035 0.2799 0.6934
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.0044 0.3879 1
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0044 0.3879 0.3653
Trichomonas vaginalis PIKK family atypical protein kinase 0.0044 0.3879 0.3879
Trichomonas vaginalis PIKK family atypical protein kinase 0.0033 0.2521 0.2521
Trichomonas vaginalis PIKK family atypical protein kinase 0.0015 0.0355 0.0355
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.1436 0.1436
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.144 0.144
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.0044 0.3879 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.2794 0.2794
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.1436 0.1436
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.1745 0.1745
Trichomonas vaginalis PIKK family atypical protein kinase 0.0038 0.3104 0.3104
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.1745 0.1745
Schistosoma mansoni serine/threonine protein kinase 0.0095 1 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0044 0.3879 0.3653
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0021 0.1085 0.207
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.0044 0.3879 1
Trichomonas vaginalis AGC family protein kinase 0.0095 1 1
Giardia lamblia GTOR 0.0044 0.3879 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.144 0.144
Trichomonas vaginalis PIKK family atypical protein kinase 0.0015 0.0355 0.0355
Trichomonas vaginalis PIKK family atypical protein kinase 0.0015 0.0355 0.0355
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0018 0.078 0.1204
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.1436 0.1436
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.1714 0.1714
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.144 0.144
Entamoeba histolytica protein kinase, putative 0.0095 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0033 0.2521 0.2521
Trichomonas vaginalis PIKK family atypical protein kinase 0.0033 0.2521 0.2521
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.0044 0.3879 0.3653
Echinococcus multilocularis 3 phosphoinositide dependent protein kinase 1 0.0095 1 1
Toxoplasma gondii target of rapamycin (TOR), putative 0.0033 0.2521 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.1745 0.1745
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.2794 0.2794
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.0044 0.3879 1
Trichomonas vaginalis AGC family protein kinase 0.0095 1 1
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.0044 0.3879 0.3653
Loa Loa (eye worm) AGC/PDK1 protein kinase 0.0095 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0044 0.3879 0.3879
Trichomonas vaginalis PIKK family atypical protein kinase 0.0015 0.0355 0.0355
Trichomonas vaginalis PIKK family atypical protein kinase 0.0033 0.2521 0.2521
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.2794 0.2794
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.2794 0.2794
Trypanosoma brucei target of rapamycin kinase 3, putative 0.0035 0.2799 0.6934
Trichomonas vaginalis PIKK family atypical protein kinase 0.0015 0.0355 0.0355
Trichomonas vaginalis PIKK family atypical protein kinase 0.0029 0.2019 0.2019
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.2794 0.2794
Loa Loa (eye worm) AGC/PDK1 protein kinase 0.0095 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.1714 0.1714
Brugia malayi Protein kinase domain containing protein 0.0095 1 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 14 % Percent inhibition of [3H]-PSB-11 binding to human Adenosine A3 receptor at 10 uM ChEMBL. 11906291
Inhibition (binding) = 14 % Percent inhibition of [3H]-PSB-11 binding to human Adenosine A3 receptor at 10 uM ChEMBL. 11906291
Inhibition (binding) = 35 % Inhibition of [3H]-CCPA binding against human Adenosine A1 receptor ChEMBL. 11906291
Inhibition (binding) = 35 % Inhibition of [3H]-CCPA binding against human Adenosine A1 receptor ChEMBL. 11906291
Ki (binding) = 53.4 nM Inhibition of [3H]-ZM-241,385 binding to human adenosine A2B receptor ChEMBL. 11906291
Ki (binding) = 53.4 nM Inhibition of [3H]-ZM-241,385 binding to human adenosine A2B receptor ChEMBL. 11906291
Ki (binding) = 2200 nM Inhibition of [3H]-CCPA binding to rat adenosine A1 receptor ChEMBL. 11906291
Ki (binding) = 2200 nM Inhibition of [3H]-CCPA binding to rat adenosine A1 receptor ChEMBL. 11906291
Ki (binding) = 24000 nM Inhibition of [3H]-MSX-2 binding to rat adenosine A2A receptor ChEMBL. 11906291
Ki (binding) = 24000 nM Inhibition of [3H]-MSX-2 binding to rat adenosine A2A receptor ChEMBL. 11906291
Ratio (binding) = 453 Selectivity ratio of the compound( A2A/A2B) ChEMBL. 11906291
Ratio (binding) = 41 Selectivity ratio of the compound (A1/A2B) ChEMBL. 11906291
Ratio (binding) > 180 Selectivity ratio (A3/A2B). ChEMBL. 11906291
Ratio (binding) = 453 Selectivity ratio of the compound( A2A/A2B) ChEMBL. 11906291

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.